Inventor · disambiguated record
Dexter Davis
Also filed as: DAVIS DEXTER · Davis Dexter Cameron
15 granted patents·3 pending applications·36 citations·filing 2016–2023
89Inventor score
Top patents by PatentIndex Score
18 records- 0195US11358953B2Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Granted Jun 14, 2022·15 cites·10 claims
- 0294US10865211B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2019·Granted Dec 15, 2020·11 cites·17 claims
- 0393US11891393B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2021·Granted Feb 6, 2024·2 cites·20 claims
- 0493US11198693B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2019·Granted Dec 14, 2021·6 cites·20 claims
- 0584US11091437B2Aryl isonitriles as a new class of antimicrobial compoundsPURDUE RESEARCH FOUNDATION·Filed 2019·Granted Aug 17, 2021·1 cites·4 claims
- 0683US12264159B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2023·Granted Apr 1, 2025·0 cites·19 claims
- 0778US10364224B2Aryl isonitriles as a new class of antimicrobial compoundsPURDUE RESEARCH FOUNDATION·Filed 2016·Granted Jul 30, 2019·1 cites·10 claims
- 0874US11098014B2Aryl isonitriles as a new class of antimicrobial compoundsPURDUE RESEARCH FOUNDATION·Filed 2019·Granted Aug 24, 2021·0 cites·8 claims
- 0969US11198674B2Aryl isonitriles as a new class of antimicrobial compoundsPURDUE RESEARCH FOUNDATION·Filed 2019·Granted Dec 14, 2021·0 cites·5 claims
- 1068US2022041652A1Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Application pending·0 cites
- 1167US11814396B2Sesquiterpenoid analogsPURDUE RESEARCH FOUNDATION·Filed 2021·Granted Nov 14, 2023·0 cites·2 claims
- 1267US2022033383A1Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Application pending·0 cites
- 1362US11518770B2Sesquiterpenoid analogsPURDUE RESEARCH FOUNDATION·Filed 2019·Granted Dec 6, 2022·0 cites·6 claims
- 1462US11377450B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2020·Granted Jul 5, 2022·0 cites·21 claims
- 1554US11802125B2Functionalized heterocyclic compounds as antiviral agentsENANTA PHARM INC·Filed 2021·Granted Oct 31, 2023·0 cites·9 claims
- 1654US2022048944A1Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Application pending·0 cites
- 1753US11738019B2Substituted heterocycles as antiviral agentsENANTA PHARM INC·Filed 2020·Granted Aug 29, 2023·0 cites·15 claims
- 1852US11236108B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2020·Granted Feb 1, 2022·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →